The US Food and Drug Administration is developing a plan for resuming surveillance inspections suspended by the COVID-19 pandemic, according to a statement commissioner Stephen Hahn issued 11 May, three days after he self-quarantined due to possible exposure to the virus.
The plan, part of President Trump’s effort to reopen an economy devastated by fear of COVID-19, comes as routine testing...







